Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preventive Antibiotics in Stroke Study
2010-018421-19Phase 4Completed
- Sponsor
- AMC Health
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ceftriaxone in stroke and post-stroke infection (SAI) (2 arms), sponsored by AMC Health. Primary endpoint: Functional outcome at 3 months (dichotomized mRS). Started Mar 2010; status: completed.
02
Drugs
ceftriaxone
03
Conditions
strokepost-stroke infection (SAI)
Beyond the preview
Go deeper on 2010-018421-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018421-19.